ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,321.41
0.25%
US Tech 100
18,228.80
-0.02%
다우존스 지수
39,872.99
0.17%
Bitcoin
70,132.39
0.00%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU
  6. Galapagos (GLPG)

  7. Galapagos (GLPG) 뉴스

GLPG

Galapagos (GLPG)

Galapagos
일자:
정렬 기준:
 검색 관련기사 보기:EU:GLPG
일자시간출처헤드라인심볼기업
2024/05/1705:01GlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
2024/05/1705:01GlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
2024/05/1605:01GlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
2024/05/1605:01GlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
2024/05/0305:01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
2024/05/0305:01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
2024/05/0105:01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
2024/05/0105:01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
2024/04/0505:01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
2024/04/0505:01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
2024/03/2905:01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
2024/03/2905:01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
2024/03/2705:01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
2024/03/2705:01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
2024/02/2306:01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
2024/02/2306:01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
2024/02/1606:01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
2024/02/1606:01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
2024/02/0106:01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
2024/02/0106:01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
2024/01/0506:44Dow Jones NewsGalapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer DrugEU:GLPGGalapagos
2024/01/0506:01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
2024/01/0506:01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
2024/01/0406:01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
2024/01/0406:01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
2024/01/0215:00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
2024/01/0215:00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
2023/12/2006:01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
2023/12/2006:01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
2023/12/1002:00GlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101EU:GLPGGalapagos
 검색 관련기사 보기:EU:GLPG

최근 히스토리

ASX
PNT
Panther Metals
KUCN
AURORAUSDT
Aurora
EU
4647T
4647T
EU
S821S
S821S
LATK
ESTIBTC
Easticoin
NASDAQ
PAYOW
Payoneer Global
BOV
ABAM34
ABN AMRO Bank N.V
LSE
FA21
Alc Sukuk 28 S
XE
SETG
Sa1 Issuer
MRTX
FBNBTC
FiveBalance
BIT
F17567
Vontobel Financial Produ...
ASX
BHPKOM
LSE
CHRT
Cohort
COIN
KGTGBP
XE
WELG
Amundi Index Solutions
BIT
UV4L46
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유